|
- Pharmacotherapy – Medications – Recovery Research Institute
Pharmacotherapy – Medications Pharmacotherapy (pharmacology) is the treatment of a disorder or disease with medication In the treatment of addiction, medications are used to reduce the intensity of withdrawal symptoms, reduce alcohol and other drug cravings, and reduce the likelihood of use or relapse for specific drugs by blocking their effect
- Bridging the Divide: How Medicine Twelve-Step Can Work Together to . . .
As a result, although medication can aid addiction recovery, most who would benefit from pharmacotherapy have limited access to it Conversely, Twelve-Step based treatment programs, as well as Twelve-Step meeting attendance are known to support addiction recovery, yet Twelve-Step facilitation is rarely offered in medically operated treatment
- Pharmacotherapy for Alcohol Use Disorders in Outpatient Settings
Pharmacotherapy for Alcohol Use Disorders in Outpatient Settings The review and meta-analysis by Jonas and colleagues examines the benefits and potential harms of approved medication for adults with alcohol use disorders The medications that were examined are often combined with other behavioral outpatient treatment
- Can certain alcohol use disorder medications help reduce risk for . . .
Pharmacotherapy is underutilized as a treatment option for alcohol use disorder though research shows certain medications may improve alcohol outcomes Research on pharmacotherapy health outcomes beyond alcohol consumption in real-world settings can provide important knowledge on their overall clinical and public health utilities
- Harm Reduction – Recovery Research Institute
Visit the post for more Harm Reduction Policies, programs, and practices that aim to reduce the harms associated with the use of alcohol or other drugs Harm reduction is an approach that promotes health in a way that meets people where they are at, accepting that not everyone is ready or capable of stopping their substance use at a given time Instead of making judgments about where
- While medications show promise, those effective for amphetamine use . . .
For individuals and families seeking recovery: There are currently no FDA-approved medications for amphetamine use disorder, and it is too soon to recommend any of the above-mentioned treatments as front-line treatments for amphetamine use disorder Although additional research is needed, of the medications reviewed in the current study, methylphenidate and topiramate demonstrated the most
- Testing the combination of bupropion and extended-release naltrexone . . .
Despite dozens of clinical trials costing many millions of dollars there are no FDA-approved medications for stimulant use disorders, such as cocaine or methamphetamine This study investigated whether the combination of bupropion – which has shown promise in reducing stimulant use – and extended-release naltrexone – FDA-approved for both alcohol and opioid use disorder – improves
- Treating youth with opioid use disorder: Can medication keep young . . .
Treating youth with opioid use disorder: Can medication keep young people from discontinuing treatment? Medications for treating opioid use disorder are effective therapeutic approaches for adults, but we know significantly less about their use among youth This study suggests that youth receiving pharmacotherapy were substantially less likely to discontinue treatment and behavioral services
|
|
|